Thousand Oaks, CA, United States of America

Wenge Zhong

This inventor holds 42 USPTO granted patents and 19 published patent applications, plus 1 CIPO patent and 12 EPO patents, primarily in Beta-Secretase Modulators. Top assignees: Amgen Inc., Qilu Regor Therapeutics Inc., Regor Pharmaceuticals, Inc.. Active years: 2004-2026.

USPTO Granted Patents = 42 (Patent Applications = 19)

% Patents Active = 97.6

CIPO Patents = 1 (Patent Applications = 12)

EPO Patents = 12 (Patent Applications = 21)

Average Co-Inventor Count = 5.6

ph-index = 6

Forward Citations = 112(Granted Patents)

Location History:

Thousands Oaks, CA (US) (2010)
Thousand Oaks, CA (US) (2004 - 2023)

Company Filing History:

Qilu Regor Therapeutics Inc.

patents

3 out of 3

Regor Pharmaceuticals, Inc.

Years Active: 2004-2026

Loading Chart...

Areas of Expertise:

Beta-Secretase

PDE10 Inhibitors

GLP-1R Agonists

HPK1 Inhibitors

Amino-Dihydrothiazine

Heterobicyclic Compounds

TRPM8 Antagonists

Spiro-Amino-Compounds

Substituted Hydroxyethyl Amine

Crystal Forms

Unsaturated Nitrogen Heterocycles

Azetidine Compounds

42 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12708623 - CDK INHIBITORS (2026-08-18),

2. 12698272 - Sting antagonists and uses thereof (2026-08-04),

3. 12692263 - SOS1 inhibitors and uses thereof (2026-07-28),

4. 12617811 - HPK1 inhibitors and uses thereof (2026-05-05),

5. 12612424 - HPK1 inhibitors and uses thereof (2026-04-28),

6. 12516041 - Crystal forms of GLP-1R agonists and uses thereof (2026-01-06),

7. 12365670 - GLP-IR agonists and uses thereof (2025-07-22),

8. 12285429 - CDK inhibitors (2025-04-29),

9. 11591321 - GLP-1R agonists and uses thereof (2023-02-28),

10. 10954221 - GLP-1R agonists and uses thereof (2021-03-23),

11. 10844049 - GLP-1R agonists and uses thereof (2020-11-24),

12. 9718803 - Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors (2017-08-01),

13. 9556135 - Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use (2017-01-31),

14. 9493459 - Azetidine and piperidine compounds useful as PDE10 inhibitors (2016-11-15),

15. 9303028 - Azetidine and piperidine compounds useful as PDE10 inhibitors (2016-04-05),

Title: The Innovative Journey of Wenge Zhong

Introduction: Wenge Zhong, a talented inventor based in Thousand Oaks, CA, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Wenge Zhong's latest patents include a cutting-edge AI-powered healthcare device designed to revolutionize patient care, as well as a sustainable energy solution that aims to reduce carbon emissions.

Career Highlights: With a career spanning over two decades, Wenge Zhong has established himself as a visionary inventor known for his ability to transform bold ideas into tangible products. His work has garnered recognition for its impact on various industries, from healthcare to renewable energy.

Collaborations: Throughout his career, Wenge Zhong has collaborated with leading research institutions and technology companies to bring his inventions to life. His partnerships have been instrumental in pushing the boundaries of innovation and driving positive change in the world.

Conclusion: Wenge Zhong's passion for innovation and commitment to creating a better future through his inventions continue to inspire the next generation of inventors. His relentless pursuit of excellence and groundbreaking ideas solidify his position as a true pioneer in the world of technology.